Lenograstim

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Lenograstim
Clinical data
Trade names Euprotin, Granocyte, Lenobio, Neutrogin
AHFS/Drugs.com International Drug Names
ATC code L03AA10 (WHO)
Identifiers
CAS Number 135968-09-1 N
ChemSpider none
UNII 6WS4C399GB YesY
ECHA InfoCard 100.207.855
 NYesY (what is this?)  (verify)

Lenograstim is a recombinant granulocyte colony-stimulating factor which functions as an immunostimulator.[1][2] It is developed by Chugai Pharmaceuticals under the brand name Granocyte.

References[edit]

  1. ^ "USAN Council. List No. 340. New names. Lenograstim". Clin. Pharmacol. Ther. 52 (1): 113. July 1992. doi:10.1038/clpt.1992.117. PMID 1284891. 
  2. ^ Amadori S, Suciu S, Jehn U, Stasi R, Thomas X, Marie JP, Muus P, Lefrère F, Berneman Z, Fillet G, Denzlinger C, Willemze R, Leoni P, Leone G, Casini M, Ricciuti F, Vignetti M, Beeldens F, Mandelli F, De Witte T (July 2005). "Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study". Blood. 106 (1): 27–34. doi:10.1182/blood-2004-09-3728. PMC 1895135Freely accessible. PMID 15761020.